Christoph Thomssen

发表

1st International consensus guidelines for advanced breast cancer (ABC 1).

C. Hudis, K. Gelmon, G. Sledge, 2012, Breast.

Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) – Part 1 with Recommendations for the Screening, Diagnosis and Therapy of Breast Cancer Interdisziplinäre

U. Nöthlings, A. Schneeweiss, J. Huober, 2022 .

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up

H. Höfler, N. Harbeck, P. Dettmar, 1999, British Journal of Cancer.

Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer

M. Lux, P. Fasching, T. Fehm, 2022, Geburtshilfe und Frauenheilkunde.

Cardiotoxicity and oncological treatments.

C. Thomssen, D. Vordermark, A. Schlitt, 2014, Deutsches Arzteblatt international.

Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer.

N. Harbeck, P. Dettmar, C. Thomssen, 1997, British Journal of Cancer.

6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).

W. Gradishar, G. Sledge, H. Rugo, 2024, Breast.

Update Breast Cancer 2022 Part 2 – Advanced Stage Breast Cancer

M. Lux, P. Fasching, T. Fehm, 2022, Geburtshilfe und Frauenheilkunde.

Arbeitsgemeinschaft Gynäkologische Onkologie Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2024

A. Schneeweiss, O. Gluz, I. Bauerfeind, 2024, Breast Care.